Top of page

Deanna L. Kirkpatrick


Davis Polk Senior Leadership Team member and the firm’s Finance Partner. A New York Law Journal “Dealmaker” and Euromoney “Equity Capital Markets Lawyer of the Year.”

Deanna is a member of Davis Polk’s four-person Senior Leadership Team and the firm’s Finance Partner, responsible for overseeing Davis Polk's finances.

Chambers says she is “a great choice of counsel for complex debt and equity transactions, with an excellent track record in biotechnology IPOs,” and it quotes clients who appreciate that “she can command a room or any phone call she is on.” In 2021, Deanna was named a “Dealmaker of the Year” by New York Law Journal and the “Equity Capital Markets Lawyer of the Year” at Euromoney’s Women in Business Law Americas Awards.

Deanna’s practice includes IPOs and other equity, equity-linked debt and other securities offerings, spanning industries including healthcare, retail, financial institutions, utilities, oil and gas, and media. She also co-leads our special purpose acquisition company (SPAC) practice.

Besides advising issuers, she represents major investment banks as underwriters’ counsel and advises clients on securities-law matters.

Experience highlights

Deanna has advised on numerous biotech and life sciences IPOs for the following companies: SOPHiA GENETICS, GH Research, Cyteir Therapeutics, Molecular Partners, Akoya Biosciences, LAVA Therapeutics, Prometheus Biosciences, Inventiva, Generation Bio, ADC Therapeutics, Ayala Pharmaceuticals, Beam Therapeutics, Progyny, Innate Pharma S.A., BioNTech SE, Stoke Therapeutics, Orchard Therapeutics plc, Aptinyx Inc., Magenta Therapeutics, Inc., Solid Biosciences Inc., InflaRx N.V., Kala Pharmaceuticals, Inc., Dova Pharmaceuticals, Inc., Jounce Therapeutics, Inc., Patheon N.V., Cynapsus Therapeutics Inc. and Oxford Immunotec.

Deanna also advises major retail clients such as VF Corporation, Walgreens and L Brands.

Deanna has advised on numerous SPAC IPOs by the following: Decarbonization Plus Acquisition Corp. II and III, Disruptive Acquisition Corporation I, Virgin Group Acquisition Corp. II, Kadem Sustainable Impact Corp., Silver Spike Acquisition Corp. II, Frontier Acquisition Corp., PWP Forward Acquisition Corp. I, Aurora Acquisition Corp., Anzu Special Acquisition Corp. I, Freedom Acquisition I Corp., Austerlitz Acquisition Corporation I and II, Soaring Eagle Acquisition Corp., Figure Acquisition Corp. I, Tuatara Capital Acquisition Corporation, Priveterra Acquisition Corp., Thimble Point Acquisition Corp., CC Neuberger Principal Holdings III, Climate Real Impact Solutions II, Science Strategic Acquisition Corp. and Primavera Capital Acquisition Corp. among many more.

Deanna has also participated in securities offerings by Fortune 500 companies such as Abbott, DXC, Hess and Lockheed Martin.

She has also represented virtually all the major investment banks, including JPMorgan Chase, Citi, Goldman Sachs and Morgan Stanley as underwriters’ counsel in equity and debt offerings and regularly advises investment banking clients on securities law-related matters.

View all experience




New York Law Journal – "Dealmaker of the Year," 2021

Euromoney Women in Business Law Americas Awards – “Equity Capital Markets Lawyer of the Year,” 2021

New York Law Journal – "Distinguished Leader," 2017

Law360 – "Capital Markets MVP," 2016

Euromoney Women in Business Law Americas Awards – “Best in Capital Markets,” 2013

Chambers USA – SPACs

Chambers USA – Capital Markets: Debt & Equity: Eastern United States

Chambers Global – Capital Markets: Debt & Equity

M.B.A./LL.B., University of Western Ontario
B.A., Queen's University
Professional history
  • Senior Leadership Team, 2019-present
  • Finance Partner, 2011-present
  • Partner, 1997-present
  • Associate, 1989-1997
Qualifications and admissions
  • State of New York
Back to top